Medical Marijuana Remedies have appearing in medical literature has shown established effects in the treatment of nausea, vomiting, premenstrual syndrome, unintentional weight loss, insomnia, lack of appetite, muscle spasticity, painful conditions such as neurogenic pain, movement disorders, asthma, and glaucoma. Also, preliminary studies have indicated that cannabis may prove useful in the treatment of inflammatory bowel disease, migraines, fibromyalgia, and similar conditions. Medical Marijuana has also been known to relieve certain symptoms of multiple sclerosis and spinal cord injuries through antispasmodic and muscle-relaxant properties as well as stimulating appetite.
Below is some recent uses for marijuana in medical studies and their effects.
HIV / AIDS
Researchers at Columbia University published clinical trial data in 2007 that showed that HIV/AIDS patients who inhaled cannabis four times a day had significant increases in food intake with little evidence of discomfort and no impairment of cognitive performance. The conclusion of their results is that smoked marijuana had a clear medical benefit in HIV-positive patients. In another 2008 study from the University of California, San Diego School of Medicine it was found that marijuana made significant reductions in the patient’s HIV-related neuropathic pain in addition to the patient’s already prescribed pain management program and may even be an effective option for pain relief for those whose pain is not being properly controlled under current medications. Changes in mood, physical disabilities, and quality of life all improved with significant results throughout the study treatment. Although pain management with opioids and other therapies have helped in many cases, neuropathic pain continues to reduce the quality of life and activity of HIV-infected patients. Cannabinoid receptors in the central and peripheral nervous systems have been shown to control pain perception and no serious adverse effects have been reported according to a study published by the American Academy of Neurology.
Marijuana has shown to help patients coping with the effects of chemotherapy by helping ease pain and regain appetite after going through intense chemotherapy sessions.
Spasticity in Multiple Sclerosis
There has been a study conducted on the effects of marijuana and Multiple Sclerosis in which the author postulates that “cannabinoids may provide neuroprotective and anit-inflammatory benefits in MS.
Research from the Scripps Research Institute in California has shown that THC, the active ingredient in marijuana, prevents the formation of deposits in the brain associated with Alzheimer’s disease. THC, it was found, prevents an enzyme called acetylcholinesterase from accelerating the formation of “Alzheimer plaques” in the brain more effectively than commercially marketed drugs and also more effective in blocking clumps of protein that can inhibit memory and cognition in Alzheimer’s patients as reported in Molecular Pharmaceutics.
In humans, drug treatment subjects who use cannabis intermittently have been found to be more likely to adhere to treatment for opioid dependence.
Medical Marijuana for severe Arthritis pain is a Health Canada accepted Category 1 condition. Recent research shows that Medical Marijuana is a strong analgesic (pain-reliever) and has been found to be an effective pain reliever when used by itself or in conjunction with other pain-relievers to safely and effectively alleviate the pain of severe arthritis.
Medical Marijuana Remedies from Health Canada
In Canada, the regulation on access to marijuana for medical purposes, established by Health Canada in July 2001, defines two categories of patients eligible for access to medical cannabis. Category 1 covers any symptoms treated within the context of providing compassionate end-of-life care or the symptoms associated with medical conditions listed below:
This classification pertains to treatment for relief in the area of end-of-life care or in relation to symptoms with regards to specific medical conditions, which are outlined in the Schedule to the Regulations, most notably:
- Acute physical pain as a result of spinal cord injury.
- Acute physical pain as a result of a debilitating spinal cord disease.
- Acute physical pain, nausea, anorexia, cachexia, and/or extreme weight loss resulting from the effects of cancer and its treatments.
- Acute physical pain, nausea, anorexia, cachexia, and/or extreme weight loss resulting from the effects of HIV/AIDS infection.
- Acute physical pain as a result of debilitating forms of arthritis.
- Acute pain as a result of epileptic seizures.
All applications have to provide a full declaration of the patient’s physical ailment provided by the patient’s medical practitioner to support the application.
This classification pertains to people incapacitating medical symptoms or conditions asides from those that were outlined in Category 1.
People with incapacitating symptoms or conditions are allowed to apply for an Authorization to Posses dried marijuana for medical purposes under the concessions provided under Category 2 as long as a specialist believes, through diagnosis, that other treatments have either failed or are inappropriate to provide relief to the problems associated with the medical condition.
Although it is required to have the applicant’s case assessed by a specialist, the patients physician, whether a specialist or not, is allowed to sign the medical declaration for the application for possession of medical marijuana.
To find out how we can further help you obtain a Medical Marijuana license feel free to contact us and also review the links below for more information.
Application forms for Medical Marijuana patient's license can found here.
-To ensure whether you qualify as a patient and to obtain legal dosage information, click here.
-Health Canada information for health practitioners can be found here.